Nicole Allison
Clinical Nurse Specialist · Providence, RINPI 1285660670
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 669 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 27.1% of the total.
Across 669 payments — averaging $21.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$4K
- Vanda Pharmaceuticals Inc.$2K
- Otsuka America Pharmaceutical, Inc.$1K
- Alkermes, Inc.$1K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$699
- plus $4K from 18 others
What the payments were for
- Food & beverage$14,131100%
- Education$270%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 173 | $3,833 |
| Vanda Pharmaceuticals Inc. | 61 | $1,509 |
| Otsuka America Pharmaceutical, Inc. | 73 | $1,475 |
| Alkermes, Inc. | 44 | $1,118 |
| Takeda Pharmaceuticals U.S.A., Inc. | 54 | $1,042 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 30 | $699 |
| Neurocrine Biosciences, Inc. | 30 | $653 |
| Lundbeck LLC | 37 | $595 |
| Corium, LLC | 29 | $563 |
| Sunovion Pharmaceuticals Inc. | 30 | $521 |
| Axsome Therapeutics, Inc. | 22 | $514 |
| Teva Pharmaceuticals USA, Inc. | 26 | $478 |
| Tris Pharma Inc | 17 | $312 |
| Johnson & Johnson | 10 | $251 |
| Neos Therapeutics, LP | 9 | $172 |
| Collegium Pharmaceutical, Inc. | 6 | $108 |
| Bausch Health US, LLC | 4 | $79 |
| Eisai Inc. | 4 | $67 |
| Supernus Pharmaceuticals, Inc. | 4 | $57 |
| Almatica Pharma LLC | 2 | $32 |
| Ironshore Pharmaceuticals Inc. | 1 | $24 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $21 |
| Invivyd Inc | 1 | $20 |
| Tonix Medicines, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few clinical nurse specialist providers in Rhode Islandto place this figure against a meaningful peer group, so we don't.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrintellixVortioxetine Hydrobromide | 22 | $13,091 |
| Aripiprazole | 23 | $3,860 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 48 | $1,613 |
| Bupropion Hcl SrBupropion Hcl | 62 | $847 |
| Duloxetine Hcl | 62 | $777 |
| Dextroamphetamine Sulfate | 17 | $766 |
| Lamotrigine | 49 | $693 |
| Paroxetine Hcl | 38 | $682 |
| Clonazepam | 79 | $666 |
| Bupropion XlBupropion Hcl | 15 | $627 |
| Venlafaxine Hcl | 13 | $402 |
| Lurasidone Hcl | 12 | $390 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 32 | $358 |
| Trazodone Hcl | 55 | $327 |
| Fluoxetine Hcl | 22 | $309 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $1,042 | $13,09122 claims |
| Almatica Pharma LLCSertraline Hcl | $32 | $10712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few clinical nurse specialist providers in Rhode Islandon file to place this against a meaningful peer group, so we don't.
Other clinical nurse specialist in Providence
- Sharon MurrayProvidence$456
- Sally HarrisonProvidence$17
- Ann Back PriceProvidence$15
- Irene DematteoWarwick$9K
- Brian HickeyWarwick$8K
- Patricia ReposaWarwick$7K
- Robert HamelEast Greenwich$552
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.